Ftse Mib
35.090,23
-0,64%
DAX
20.214,79
-0,51%
S&P 500
5.827,04
-1,54%
NASDAQ
19.161,63
-1,63%
Bitcoin
94.089,30
-0,42%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Oruka Therapeutics Inc (ORKA) Oruka Therapeutics Inc (ORKA) Notizie

Oruka Therapeutics Inc

ORKA
15,72
-3,29 (-17,31%)
11 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
19/12/202413:16EDGAR2Form 8-K - Current report
19/12/202413:00GLOBEOruka Therapeutics Announces First Participants Dosed in..
18/12/202413:00GLOBEOruka Therapeutics to be Added to the Nasdaq Biotechnology..
27/11/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
22/11/202400:30EDGAR2Form SC 13D/A - General Statement of Acquisition of..
22/11/202400:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/11/202414:00GLOBEOruka Therapeutics to Present at Piper Sandler’s 36th Annual..
18/11/202422:10EDGAR2Form 8-K - Current report
15/11/202401:38EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202423:49EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202423:20EDGAR2Form S-8 - Securities to be offered to employees in employee..
14/11/202422:56EDGAR2Form 8-K - Current report
14/11/202418:04EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202415:56EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202412:37EDGAR2Form S-1 - General form for registration of securities under..
13/11/202422:25GLOBEOruka Therapeutics Reports Third Quarter 2024 Financial..
13/11/202422:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/11/202413:00GLOBEOruka Therapeutics to Present at Multiple November Investor..
22/10/202422:15EDGAR2Form SC 13D/A - General Statement of Acquisition of..
18/10/202422:11EDGAR2Form DEF 14A - Other definitive proxy statements
04/10/202422:05EDGAR2Form 8-K - Current report
25/9/202413:08GLOBEOruka Therapeutics Announces Preclinical Data for ORKA-001..
13/9/202422:57EDGAR2Form SC 13D/A - General Statement of Acquisition of..
13/9/202422:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202422:02EDGAR2Form 8-K - Current report
12/9/202413:05GLOBEOruka Therapeutics Announces $200 Million Private Placement
12/9/202413:00GLOBEOruka Therapeutics Announces Accelerated Clinical Timelines..
06/9/202423:08EDGAR2Form SC 13D - General Statement of Acquisition of Beneficial..
06/9/202423:07EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/9/202423:07EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/9/202423:06EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/9/202423:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/9/202423:04EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/9/202423:03EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/9/202423:02EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/9/202423:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/9/202423:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/9/202413:00GLOBEOruka Therapeutics Announces Closing of Merger with ARCA..
Apertura: 18,72 Min: 15,6281 Max: 18,765
Chiusura: 19,01

La tua Cronologia

NASDAQ
ORKA
Oruka Therapeutics
BIT
UR9QAQ
UniCredit Bank
NASDAQ
BRHY
BlackRock ETF Trust II i...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network